Clinical Trials Browser

Phase 2 × INDUSTRY × ProMune × Clear all

NCT00471159 2015-05-04

A Study Of Docetaxel Or Docetaxel Plus PF-3512676 To Treat Patients With Advanced Breast Cancer.

Phase 2 Withdrawn

Breast Neoplasms

NCT00321815 2010-12-23

Trial Of Erlotinib With Or Without PF-3512676 In Advanced Non Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT00313768 2009-09-28

Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLC

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung

NCT00321308 2009-09-28

Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung

NCT00043368 2009-03-12

PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)

Phase 2 Completed

BreastDermatologicGenitourinaryLymphoidThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Lymphoma, T-Cell

NCT00043394 2009-03-12

CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT00070629 2009-02-10

CPG 7909 Injection in Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00070642 2009-02-10

CPG 7909 Injection in Melanoma

Phase 2 Completed

Carcinoma, Melanoma, Skin Neoplasms